[
  {
    "resourceType": "RequestGroup",
    "id": "2",
    "subject": {
      "reference": "Patient/f54452ab-9215-4f82-b904-282b1999ba6f",
      "display": "Joanne Smith"
    },
    "instantiatesCanonical": "http://OUR-PLACEHOLDER-URL.com/PlanDefinition/CervicalCancerScreening",
    "intent": "proposal",
    "status": "draft",
    "action": [
      {
        "id": "3",
        "title": "Cervical Cancer Screening Actions",
        "description": "Top level action that defines trigger and criteria for inclusion and exclusion.",
        "documentation": [
          {
            "type": "documentation",
            "label": "Inclusions",
            "display": "Appropriate for individuals whose sex at birth is recorded as Female or whose gender identity is recorded as Transgender Male."
          }
        ],
        "textEquivalent": "Static text equivalent of the action, used if the dynamic aspects cannot be interpreted by the receiving system",
        "action": [
          {
            "id": "4",
            "title": "Display pertinent medical history",
            "description": "DISPLAY data elements used in the Cervical Cancer Screening and Management Dashboard",
            "textEquivalent": "Static text equivalent of the action, used if the dynamic aspects cannot be interpreted by the receiving system",
            "resource": {
              "reference": "CommunicationRequest/7"
            }
          },
          {
            "id": "10",
            "title": "Screening Decision Aids",
            "description": "Screening Decision Aids",
            "documentation": [
              {
                "type": "citation",
                "label": "Screening: Average Risk",
                "display": "2018 USPSTF Cervical Cancer Screening Recommendations",
                "citation": "United States Preventive Services Task Force, \"Final Recommendation Statement: Cervical Cancer Screening,\" 21 August 2018.",
                "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/cervical-cancer-screening"
              },
              {
                "type": "citation",
                "label": "Screening: Symptomatic",
                "display": "Evaluation of the Cervix in Patients with Abnormal Vaginal Bleeding",
                "citation": "ASCCP Clinical Practice Statement, \"Evaluation of the Cervix in Patients with Abnormal Vaginal Bleeding,\" 7 February 2017.",
                "url": "https://www.asccp.org/Assets/9d92e617-858f-43f3-af62-44adf76cfc67/636220616039000000/vaginal-bleeding-statement-final-02-06-17-pdf"
              },
              {
                "type": "citation",
                "label": "Screening: DES Exposure",
                "display": "Practice Bulletin No. 168: Cervical Cancer Screening and Prevention",
                "citation": "\"Practice Bulletin No. 168: Cervical Cancer Screening and Prevention,\" Obstetrics and Gynecology, vol. 1284, no. 4, pp. e111-e130, 2016.",
                "url": "https://pubmed.ncbi.nlm.nih.gov/27661651/"
              },
              {
                "type": "citation",
                "label": "Screening: DES Exposure",
                "display": "Antenatal exposure to DES: Lessons Learned...Future Concerns",
                "citation": "M. Rubin, \"Antenatal exposure to DES: Lessons Learned...Future Concerns,\" Obstetrical & Gynecological Survey, vol. 62, no. 8, pp. 548-555, 2007.",
                "url": "https://pubmed.ncbi.nlm.nih.gov/17634156/"
              },
              {
                "type": "citation",
                "label": "Screening: Immunocompromised",
                "display": "Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV",
                "citation": "Panel on Opportunistic Infections in Adults and Adolescents with HIV, \"Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: Recommendations from the CDC, the NIH, and the HIV Medicine Association of the Infectious Diseases Society of America,\" 29 November 2018.",
                "url": "https://clinicalinfo.hiv.gov/en/guidelines/adult-and-adolescent-opportunistic-infection/human-papillomavirus-disease"
              },
              {
                "type": "citation",
                "label": "Screening: Immunocompromised",
                "display": "Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection",
                "citation": "A.-B. Moscicki, L. Flowers, M. J. Huchko, M. E. Long, K. L. MacLaughlin, J. Murphy, L. B. Spiryda and M. A. Gold, \"Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection,\" Journal of Lower Genital Tract Disease, vol. 23, no. 2, pp. 87-101, 2019.",
                "url": "https://pubmed.ncbi.nlm.nih.gov/30907775/"
              }
            ],
            "textEquivalent": "Screening Decision Aids",
            "resource": {
              "reference": "CommunicationRequest/15"
            }
          },
          {
            "id": "11",
            "title": "Recommended Screening Activities",
            "description": "Recommended Screening Activities",
            "textEquivalent": "Recommended Screening Activities",
            "groupingBehavior": "visual-group",
            "selectionBehavior": "at-most-one",
            "action": [
              {
                "id": "12",
                "title": "Primary HPV",
                "documentation": [
                  {
                    "type": "citation",
                    "label": "Screening: Average Risk",
                    "display": "2018 USPSTF Cervical Cancer Screening Recommendations",
                    "citation": "United States Preventive Services Task Force, \"Final Recommendation Statement: Cervical Cancer Screening,\" 21 August 2018.",
                    "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/cervical-cancer-screening"
                  },
                  {
                    "type": "citation",
                    "label": "Screening: Symptomatic",
                    "display": "Evaluation of the Cervix in Patients with Abnormal Vaginal Bleeding",
                    "citation": "ASCCP Clinical Practice Statement, \"Evaluation of the Cervix in Patients with Abnormal Vaginal Bleeding,\" 7 February 2017.",
                    "url": "https://www.asccp.org/Assets/9d92e617-858f-43f3-af62-44adf76cfc67/636220616039000000/vaginal-bleeding-statement-final-02-06-17-pdf"
                  },
                  {
                    "type": "citation",
                    "label": "Screening: DES Exposure",
                    "display": "Practice Bulletin No. 168: Cervical Cancer Screening and Prevention",
                    "citation": "\"Practice Bulletin No. 168: Cervical Cancer Screening and Prevention,\" Obstetrics and Gynecology, vol. 1284, no. 4, pp. e111-e130, 2016.",
                    "url": "https://pubmed.ncbi.nlm.nih.gov/27661651/"
                  },
                  {
                    "type": "citation",
                    "label": "Screening: DES Exposure",
                    "display": "Antenatal exposure to DES: Lessons Learned...Future Concerns",
                    "citation": "M. Rubin, \"Antenatal exposure to DES: Lessons Learned...Future Concerns,\" Obstetrical & Gynecological Survey, vol. 62, no. 8, pp. 548-555, 2007.",
                    "url": "https://pubmed.ncbi.nlm.nih.gov/17634156/"
                  },
                  {
                    "type": "citation",
                    "label": "Screening: Immunocompromised",
                    "display": "Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV",
                    "citation": "Panel on Opportunistic Infections in Adults and Adolescents with HIV, \"Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: Recommendations from the CDC, the NIH, and the HIV Medicine Association of the Infectious Diseases Society of America,\" 29 November 2018.",
                    "url": "https://clinicalinfo.hiv.gov/en/guidelines/adult-and-adolescent-opportunistic-infection/human-papillomavirus-disease"
                  },
                  {
                    "type": "citation",
                    "label": "Screening: Immunocompromised",
                    "display": "Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection",
                    "citation": "A.-B. Moscicki, L. Flowers, M. J. Huchko, M. E. Long, K. L. MacLaughlin, J. Murphy, L. B. Spiryda and M. A. Gold, \"Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection,\" Journal of Lower Genital Tract Disease, vol. 23, no. 2, pp. 87-101, 2019.",
                    "url": "https://pubmed.ncbi.nlm.nih.gov/30907775/"
                  }
                ],
                "resource": {
                  "reference": "ServiceRequest/16"
                },
                "description": "Natural language description of the activity definition"
              },
              {
                "id": "13",
                "title": "Cytology",
                "documentation": [
                  {
                    "type": "citation",
                    "label": "Screening: Average Risk",
                    "display": "2018 USPSTF Cervical Cancer Screening Recommendations",
                    "citation": "United States Preventive Services Task Force, \"Final Recommendation Statement: Cervical Cancer Screening,\" 21 August 2018.",
                    "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/cervical-cancer-screening"
                  },
                  {
                    "type": "citation",
                    "label": "Screening: Symptomatic",
                    "display": "Evaluation of the Cervix in Patients with Abnormal Vaginal Bleeding",
                    "citation": "ASCCP Clinical Practice Statement, \"Evaluation of the Cervix in Patients with Abnormal Vaginal Bleeding,\" 7 February 2017.",
                    "url": "https://www.asccp.org/Assets/9d92e617-858f-43f3-af62-44adf76cfc67/636220616039000000/vaginal-bleeding-statement-final-02-06-17-pdf"
                  },
                  {
                    "type": "citation",
                    "label": "Screening: DES Exposure",
                    "display": "Practice Bulletin No. 168: Cervical Cancer Screening and Prevention",
                    "citation": "\"Practice Bulletin No. 168: Cervical Cancer Screening and Prevention,\" Obstetrics and Gynecology, vol. 1284, no. 4, pp. e111-e130, 2016.",
                    "url": "https://pubmed.ncbi.nlm.nih.gov/27661651/"
                  },
                  {
                    "type": "citation",
                    "label": "Screening: DES Exposure",
                    "display": "Antenatal exposure to DES: Lessons Learned...Future Concerns",
                    "citation": "M. Rubin, \"Antenatal exposure to DES: Lessons Learned...Future Concerns,\" Obstetrical & Gynecological Survey, vol. 62, no. 8, pp. 548-555, 2007.",
                    "url": "https://pubmed.ncbi.nlm.nih.gov/17634156/"
                  },
                  {
                    "type": "citation",
                    "label": "Screening: Immunocompromised",
                    "display": "Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV",
                    "citation": "Panel on Opportunistic Infections in Adults and Adolescents with HIV, \"Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: Recommendations from the CDC, the NIH, and the HIV Medicine Association of the Infectious Diseases Society of America,\" 29 November 2018.",
                    "url": "https://clinicalinfo.hiv.gov/en/guidelines/adult-and-adolescent-opportunistic-infection/human-papillomavirus-disease"
                  },
                  {
                    "type": "citation",
                    "label": "Screening: Immunocompromised",
                    "display": "Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection",
                    "citation": "A.-B. Moscicki, L. Flowers, M. J. Huchko, M. E. Long, K. L. MacLaughlin, J. Murphy, L. B. Spiryda and M. A. Gold, \"Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection,\" Journal of Lower Genital Tract Disease, vol. 23, no. 2, pp. 87-101, 2019.",
                    "url": "https://pubmed.ncbi.nlm.nih.gov/30907775/"
                  }
                ],
                "resource": {
                  "reference": "ServiceRequest/17"
                },
                "description": "Natural language description of the activity definition"
              },
              {
                "id": "14",
                "title": "Cotesting",
                "documentation": [
                  {
                    "type": "citation",
                    "label": "Screening: Average Risk",
                    "display": "2018 USPSTF Cervical Cancer Screening Recommendations",
                    "citation": "United States Preventive Services Task Force, \"Final Recommendation Statement: Cervical Cancer Screening,\" 21 August 2018.",
                    "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/cervical-cancer-screening"
                  },
                  {
                    "type": "citation",
                    "label": "Screening: Symptomatic",
                    "display": "Evaluation of the Cervix in Patients with Abnormal Vaginal Bleeding",
                    "citation": "ASCCP Clinical Practice Statement, \"Evaluation of the Cervix in Patients with Abnormal Vaginal Bleeding,\" 7 February 2017.",
                    "url": "https://www.asccp.org/Assets/9d92e617-858f-43f3-af62-44adf76cfc67/636220616039000000/vaginal-bleeding-statement-final-02-06-17-pdf"
                  },
                  {
                    "type": "citation",
                    "label": "Screening: DES Exposure",
                    "display": "Practice Bulletin No. 168: Cervical Cancer Screening and Prevention",
                    "citation": "\"Practice Bulletin No. 168: Cervical Cancer Screening and Prevention,\" Obstetrics and Gynecology, vol. 1284, no. 4, pp. e111-e130, 2016.",
                    "url": "https://pubmed.ncbi.nlm.nih.gov/27661651/"
                  },
                  {
                    "type": "citation",
                    "label": "Screening: DES Exposure",
                    "display": "Antenatal exposure to DES: Lessons Learned...Future Concerns",
                    "citation": "M. Rubin, \"Antenatal exposure to DES: Lessons Learned...Future Concerns,\" Obstetrical & Gynecological Survey, vol. 62, no. 8, pp. 548-555, 2007.",
                    "url": "https://pubmed.ncbi.nlm.nih.gov/17634156/"
                  },
                  {
                    "type": "citation",
                    "label": "Screening: Immunocompromised",
                    "display": "Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV",
                    "citation": "Panel on Opportunistic Infections in Adults and Adolescents with HIV, \"Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: Recommendations from the CDC, the NIH, and the HIV Medicine Association of the Infectious Diseases Society of America,\" 29 November 2018.",
                    "url": "https://clinicalinfo.hiv.gov/en/guidelines/adult-and-adolescent-opportunistic-infection/human-papillomavirus-disease"
                  },
                  {
                    "type": "citation",
                    "label": "Screening: Immunocompromised",
                    "display": "Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection",
                    "citation": "A.-B. Moscicki, L. Flowers, M. J. Huchko, M. E. Long, K. L. MacLaughlin, J. Murphy, L. B. Spiryda and M. A. Gold, \"Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection,\" Journal of Lower Genital Tract Disease, vol. 23, no. 2, pp. 87-101, 2019.",
                    "url": "https://pubmed.ncbi.nlm.nih.gov/30907775/"
                  }
                ],
                "resource": {
                  "reference": "ServiceRequest/18"
                },
                "description": "Natural language description of the activity definition"
              }
            ]
          }
        ]
      }
    ]
  },
  [
    {
      "id": "7",
      "resourceType": "CommunicationRequest",
      "status": "option",
      "basedOn": [
        {
          "reference": "http://OUR-PLACEHOLDER-URL.com/ActivityDefinition/DisplayCervicalCancerMedicalHistory"
        }
      ],
      "subject": {
        "reference": "Patient/f54452ab-9215-4f82-b904-282b1999ba6f",
        "display": "Joanne Smith"
      },
      "payload": [
        {
          "contentString": "{\"patientInfo\":{\"name\":\"Joanne Smith\",\"isPregnant\":false,\"dateOfBirth\":{\"value\":{\"year\":1986,\"month\":1,\"day\":1}},\"sexAtBirth\":\"Unknown\",\"age\":37,\"gender\":\"Unknown\",\"primaryLanguage\":\"Unknown\",\"race\":null},\"patientHistory\":{\"conditions\":[],\"observations\":[],\"medications\":[],\"procedures\":[],\"diagnosticReports\":[{\"name\":\"Cervical Cytology\",\"longName\":\"Microscopic observation [Identifier] in Cervix by Cyto stain\",\"value\":\"NILM\",\"longValue\":[{\"value\":\"Negative for intraepithelial lesion or malignancy (finding)\"}],\"date\":\"2018-05-01\",\"reference\":\"DiagnosticReport/f52a1e33-1ca3-4619-ad98-178cd25b621a\",\"edited\":false}],\"encounters\":[],\"immunizations\":[]}}"
        }
      ]
    },
    {
      "id": "15",
      "resourceType": "CommunicationRequest",
      "status": "option",
      "basedOn": [
        {
          "reference": "http://OUR-PLACEHOLDER-URL.com/ActivityDefinition/CervicalCancerDecisionAids"
        }
      ],
      "subject": {
        "reference": "Patient/f54452ab-9215-4f82-b904-282b1999ba6f",
        "display": "Joanne Smith"
      },
      "payload": [
        {
          "contentString": "{\"recommendation\":\"Cervical Screening Due Now\",\"recommendationGroup\":\"Screening: Average Risk\",\"recommendationDetails\":[\"Per USPSTF guidelines, this patient is due for cervical cancer screening. The screening can be performed by using: 1) cervical cytology testing alone, 2) hrHPV testing alone, or 3) cotesting with cervical cytology testing and hrHPV testing.\"],\"recommendationDate\":\"2023-04-17\",\"errors\":[],\"disclaimer\":\"An evidence based recommendation is provided based on clinical data available in the patient's electronic medical record. Please validate with patient and document any additional relevant history and cervical cancer screening related procedures, and lab testing with documented written evidence.\",\"suggestedOrders\":[\"Primary HPV\",\"Cytology\",\"Cotest\"]}"
        }
      ]
    },
    {
      "id": "16",
      "resourceType": "ServiceRequest",
      "status": "option",
      "basedOn": [
        {
          "reference": "http://OUR-PLACEHOLDER-URL.com/ActivityDefinition/CervicalCancerScreeningActivity"
        }
      ],
      "subject": {
        "reference": "Patient/f54452ab-9215-4f82-b904-282b1999ba6f",
        "display": "Joanne Smith"
      },
      "intent": "proposal",
      "orderDetail": [
        {
          "text": "Per USPSTF guidelines, this patient is due for cervical cancer screening. The screening can be performed by using: 1) cervical cytology testing alone, 2) hrHPV testing alone, or 3) cotesting with cervical cytology testing and hrHPV testing."
        }
      ],
      "occurrenceDateTime": "2023-04-17",
      "code": {
        "coding": [
          {
            "system": "http://OUR-PLACEHOLDER-URL.com",
            "code": "hpv",
            "display": "Primary HPV"
          }
        ],
        "text": "Primary HPV"
      }
    },
    {
      "id": "17",
      "resourceType": "ServiceRequest",
      "status": "option",
      "basedOn": [
        {
          "reference": "http://OUR-PLACEHOLDER-URL.com/ActivityDefinition/CervicalCancerScreeningActivity"
        }
      ],
      "subject": {
        "reference": "Patient/f54452ab-9215-4f82-b904-282b1999ba6f",
        "display": "Joanne Smith"
      },
      "intent": "proposal",
      "orderDetail": [
        {
          "text": "Per USPSTF guidelines, this patient is due for cervical cancer screening. The screening can be performed by using: 1) cervical cytology testing alone, 2) hrHPV testing alone, or 3) cotesting with cervical cytology testing and hrHPV testing."
        }
      ],
      "occurrenceDateTime": "2023-04-17",
      "code": {
        "coding": [
          {
            "system": "http://OUR-PLACEHOLDER-URL.com",
            "code": "cytology",
            "display": "Cytology"
          }
        ],
        "text": "Cytology"
      }
    },
    {
      "id": "18",
      "resourceType": "ServiceRequest",
      "status": "option",
      "basedOn": [
        {
          "reference": "http://OUR-PLACEHOLDER-URL.com/ActivityDefinition/CervicalCancerScreeningActivity"
        }
      ],
      "subject": {
        "reference": "Patient/f54452ab-9215-4f82-b904-282b1999ba6f",
        "display": "Joanne Smith"
      },
      "intent": "proposal",
      "orderDetail": [
        {
          "text": "Per USPSTF guidelines, this patient is due for cervical cancer screening. The screening can be performed by using: 1) cervical cytology testing alone, 2) hrHPV testing alone, or 3) cotesting with cervical cytology testing and hrHPV testing."
        }
      ],
      "occurrenceDateTime": "2023-04-17",
      "code": {
        "coding": [
          {
            "system": "http://OUR-PLACEHOLDER-URL.com",
            "code": "cotest",
            "display": "Cotest"
          }
        ],
        "text": "Cotest"
      }
    }
  ]
]